| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Cardiovascular Research Institute and Department of
Anatomy,*
University of California, San Francisco,
California; and the Edwin L. Steele
Laboratory,
Department of Radiation Oncology,
Massachusetts General Hospital and Harvard Medical School,
Boston, Massachusetts
Leakiness of blood vessels in tumors may contribute to disease progression and is key to certain forms of cancer therapy, but the structural basis of the leakiness is unclear. We sought to determine whether endothelial gaps or transcellular holes, similar to those found in leaky vessels in inflammation, could explain the leakiness of tumor vessels. Blood vessels in MCa-IV mouse mammary carcinomas, which are known to be unusually leaky (functional pore size 1.22 µm), were compared to vessels in three less leaky tumors and normal mammary glands. Vessels were identified by their binding of intravascularly injected fluorescent cationic liposomes and Lycopersicon esculentum lectin and by CD31 (PECAM) immunoreactivity. The luminal surface of vessels in all four tumors had a defective endothelial monolayer as revealed by scanning electron microscopy. In MCa-IV tumors, 14% of the vessel surface was lined by poorly connected, overlapping cells. The most superficial lining cells, like endothelial cells, had CD31 immunoreactivity and fenestrae with diaphragms, but they had a branched phenotype with cytoplasmic projections as long as 50 µm. Some branched cells were separated by intercellular openings (mean diameter 1.7 µm; range, 0.34.7 µm). Transcellular holes (mean diameter 0.6 µm) were also present but were only 8% as numerous as intercellular openings. Some CD31-positive cells protruded into the vessel lumen; others sprouted into perivascular tumor tissue. Tumors in RIP-Tag2 mice had, in addition, tumor cell-lined lakes of extravasated erythrocytes. We conclude that some tumor vessels have a defective cellular lining composed of disorganized, loosely connected, branched, overlapping or sprouting endothelial cells. Openings between these cells contribute to tumor vessel leakiness and may permit access of macromolecular therapeutic agents to tumor cells.
This article has been cited by other articles:
![]() |
B. Sennino, F. Kuhnert, S. P. Tabruyn, M. R. Mancuso, D. D. Hu-Lowe, C. J. Kuo, and D. M. McDonald Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors Cancer Res., May 15, 2009; 69(10): 4527 - 4536. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-K. Chang, C.-Y. Chiu, S.-Y. Kuo, W.-C. Lin, A. Lo, Y.-P. Wang, P.-C. Li, and H.-C. Wu Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors J. Biol. Chem., May 8, 2009; 284(19): 12905 - 12916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sluimer, F. D. Kolodgie, A. P.J.J. Bijnens, K. Maxfield, E. Pacheco, B. Kutys, H. Duimel, P. M. Frederik, V. W.M. van Hinsbergh, R. Virmani, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1517 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Q. Lun, J.-H. Jang, N. Tang, H. Deng, R. Head, J. C. Bell, D. F. Stojdl, C. L. Nutt, D. L. Senger, P. A. Forsyth, et al. Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide Clin. Cancer Res., April 15, 2009; 15(8): 2777 - 2788. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Blanco, C. W. Kessinger, B. D. Sumer, and J. Gao Multifunctional Micellar Nanomedicine for Cancer Therapy Experimental Biology and Medicine, February 1, 2009; 234(2): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kotz, C. West, A. Saleem, T. Jones, and P. Price Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue Mol. Cancer Ther., February 1, 2009; 8(2): 303 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, B. Tian, and K. Kostarelos Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo FASEB J, September 1, 2008; 22(9): 3389 - 3402. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ghosh, C. K. Thodeti, A. C. Dudley, A. Mammoto, M. Klagsbrun, and D. E. Ingber Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro PNAS, August 12, 2008; 105(32): 11305 - 11310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Raatschen, G. H. Simon, Y. Fu, B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, and R. C. Brasch Vascular Permeability during Antiangiogenesis Treatment: MR Imaging Assay Results as Biomarker for Subsequent Tumor Growth in Rats Radiology, May 1, 2008; 247(2): 391 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Epardaud, K. G. Elpek, M. P. Rubinstein, A.-r. Yonekura, A. Bellemare-Pelletier, R. Bronson, J. A. Hamerman, A. W. Goldrath, and S. J. Turley Interleukin-15/Interleukin-15R{alpha} Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells Cancer Res., April 15, 2008; 68(8): 2972 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jain, S.K. Ellika, L. Scarpace, L.R. Schultz, J.P. Rock, J. Gutierrez, S.C. Patel, J. Ewing, and T. Mikkelsen Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lo, C.-T. Lin, and H.-C. Wu Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery Mol. Cancer Ther., March 1, 2008; 7(3): 579 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. DeWever, F. Frerart, C. Bouzin, C. Baudelet, R. Ansiaux, P. Sonveaux, B. Gallez, C. Dessy, and O. Feron Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment Am. J. Pathol., November 1, 2007; 171(5): 1619 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tredan, C. M. Galmarini, K. Patel, and I. F. Tannock Drug Resistance and the Solid Tumor Microenvironment J Natl Cancer Inst, October 3, 2007; 99(19): 1441 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L.B. Seynhaeve, S. Hoving, D. Schipper, C. E. Vermeulen, G. aan de Wiel-Ambagtsheer, S. T. van Tiel, A. M.M. Eggermont, and T. L.M. ten Hagen Tumor Necrosis Factor {alpha} Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response Cancer Res., October 1, 2007; 67(19): 9455 - 9462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwai, G. Cao, W. Yin, R. A. Stetler, J. Liu, and J. Chen Erythropoietin Promotes Neuronal Replacement Through Revascularization and Neurogenesis After Neonatal Hypoxia/Ischemia in Rats Stroke, October 1, 2007; 38(10): 2795 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oldberg, S. Kalamajski, A. V. Salnikov, L. Stuhr, M. Morgelin, R. K. Reed, N.-E. Heldin, and K. Rubin Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma PNAS, August 28, 2007; 104(35): 13966 - 13971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dreher and A. Chilkoti Toward a Systems Engineering Approach to Cancer Drug Delivery J Natl Cancer Inst, July 4, 2007; 99(13): 983 - 985. [Full Text] [PDF] |
||||
![]() |
F. D. Kolodgie, J. Narula, C. Yuan, A. P. Burke, A. V. Finn, and R. Virmani Elimination of Neoangiogenesis for Plaque Stabilization: Is There a Role for Local Drug Therapy? J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogawa, Y. Boucher, S. Kashiwagi, D. Fukumura, D. Chen, and L. E. Gerweck Influence of Tumor Cell and Stroma Sensitivity on Tumor Response to Radiation Cancer Res., May 1, 2007; 67(9): 4016 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dreher, W. Liu, C. R. Michelich, M. W. Dewhirst, and A. Chilkoti Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors Cancer Res., May 1, 2007; 67(9): 4418 - 4424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Robertson Mig-7 Linked to Vasculogenic Mimicry Am. J. Pathol., May 1, 2007; 170(5): 1454 - 1456. [Full Text] [PDF] |
||||
![]() |
A. P. Petty, K. L. Garman, V. D. Winn, C. M. Spidel, and J. S. Lindsey Overexpression of Carcinoma and Embryonic Cytotrophoblast Cell-Specific Mig-7 Induces Invasion and Vessel-Like Structure Formation Am. J. Pathol., May 1, 2007; 170(5): 1763 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Fournier, V. Novikov, V. Lucidi, Y. Fu, T. Miller, E. Floyd, D. M. Shames, and R. C. Brasch MR Monitoring of Cyclooxygenase-2 Inhibition of Angiogenesis in a Human Breast Cancer Model in Rats Radiology, April 1, 2007; 243(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chung, A. R. Karpf, J. R. Muindi, J. M. Conroy, N. J. Nowak, C. S. Johnson, and D. L. Trump Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol J. Biol. Chem., March 23, 2007; 282(12): 8704 - 8714. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Jain, R. T. Tong, and L. L. Munn Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical Model Cancer Res., March 15, 2007; 67(6): 2729 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Lin, J. Yu, T. Murata, and W. C. Sessa Caveolin-1-Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth Cancer Res., March 15, 2007; 67(6): 2849 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liao, C. Corle, T. N. Seagroves, and R. S. Johnson Hypoxia-Inducible Factor-1{alpha} Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression Cancer Res., January 15, 2007; 67(2): 563 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takahashi, Y. Akishima-Fukasawa, N. Kobayashi, T. Sano, T. Kosuge, Y. Nimura, Y. Kanai, and N. Hiraoka Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors Clin. Cancer Res., January 1, 2007; 13(1): 187 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Ohab, S. Fleming, A. Blesch, and S. T. Carmichael A Neurovascular Niche for Neurogenesis after Stroke J. Neurosci., December 13, 2006; 26(50): 13007 - 13016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chidlow Jr., W. Langston, J. J.M. Greer, D. Ostanin, M. Abdelbaqi, J. Houghton, A. Senthilkumar, D. Shukla, A. P. Mazar, M. B. Grisham, et al. Differential Angiogenic Regulation of Experimental Colitis Am. J. Pathol., December 1, 2006; 169(6): 2014 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cheong, X. Huang, C. Bettegowda, L. A. Diaz Jr., K. W. Kinzler, S. Zhou, and B. Vogelstein A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science, November 24, 2006; 314(5803): 1308 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Lee, E. R. Gillies, M. E. Fox, S. J. Guillaudeu, J. M. J. Frechet, E. E. Dy, and F. C. Szoka A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas PNAS, November 7, 2006; 103(45): 16649 - 16654. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, N. Ferrara, and R. B. Jaffe Paracrine VEGF/VE-Cadherin Action on Ovarian Cancer Permeability. Experimental Biology and Medicine, November 1, 2006; 231(10): 1646 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hasegawa, T. Nakamura, M. Harvey, Y. Ikeda, A. Oberg, M. Figini, S. Canevari, L. C. Hartmann, and K.-W. Peng The Use of a Tropism-Modified Measles Virus in Folate Receptor-Targeted Virotherapy of Ovarian Cancer. Clin. Cancer Res., October 15, 2006; 12(20): 6170 - 6178. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chung, M. K. Wong, G. Flynn, W.-d. Yu, C. S. Johnson, and D. L. Trump Differential Antiproliferative Effects of Calcitriol on Tumor-Derived and Matrigel-Derived Endothelial Cells. Cancer Res., September 1, 2006; 66(17): 8565 - 8573. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Webster, E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu Regulation of lymph node vascular growth by dendritic cells J. Exp. Med., August 7, 2006; 203(8): 1903 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lammerts van Bueren, W. K. Bleeker, H. O. Bogh, M. Houtkamp, J. Schuurman, J. G.J. van de Winkel, and P. W.H.I. Parren Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action. Cancer Res., August 1, 2006; 66(15): 7630 - 7638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Bedikian, A. Vardeleon, T. Smith, S. Campbell, and R. Namdari Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients. J. Clin. Pharmacol., July 1, 2006; 46(7): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Provenzale, S. Mukundan, and D. P. Barboriak Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response. Radiology, June 1, 2006; 239(3): 632 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
G S Stamatakos, V P Antipas, N K Uzunoglu, and R G Dale A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density Br. J. Radiol., May 1, 2006; 79(941): 389 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Horssen, T. L. M. ten Hagen, and A. M. M. Eggermont TNF-{alpha} in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility. Oncologist, April 1, 2006; 11(4): 397 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Stefansson, H. B. Salvesen, and L. A. Akslen Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res., March 15, 2006; 66(6): 3303 - 3309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dreher, W. Liu, C. R. Michelich, M. W. Dewhirst, F. Yuan, and A. Chilkoti Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst, March 1, 2006; 98(5): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakahara, S. M. Norberg, D. R. Shalinsky, D. D. Hu-Lowe, and D. M. McDonald Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors Cancer Res., February 1, 2006; 66(3): 1434 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Diaz Jr., I. Cheong, C. A. Foss, X. Zhang, B. A. Peters, N. Agrawal, C. Bettegowda, B. Karim, G. Liu, K. Khan, et al. Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores Toxicol. Sci., December 1, 2005; 88(2): 562 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Akiyama, K. A. Mohamedali, R. L. e Silva, S. Kachi, J. Shen, C. Hatara, N. Umeda, S. F. Hackett, S. Aslam, M. Krause, et al. Vascular Targeting of Ocular Neovascularization with a Vascular Endothelial Growth Factor121/Gelonin Chimeric Protein Mol. Pharmacol., December 1, 2005; 68(6): 1543 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Cristini, H. B. Frieboes, R. Gatenby, S. Caserta, M. Ferrari, and J. Sinek Morphologic Instability and Cancer Invasion Clin. Cancer Res., October 1, 2005; 11(19): 6772 - 6779. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Yue and Z.-P. Chen Does Vasculogenic Mimicry Exist in Astrocytoma? J. Histochem. Cytochem., August 1, 2005; 53(8): 997 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Muller, G. Terszowski, C. Blum, C. Haller, V. Anquez, S. Kuschert, P. Carmeliet, H. G. Augustin, and H.-R. Rodewald Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture PNAS, July 26, 2005; 102(30): 10587 - 10592. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. di Tomaso, D. Capen, A. Haskell, J. Hart, J. J. Logie, R. K. Jain, D. M. McDonald, R. Jones, and L. L. Munn Mosaic Tumor Vessels: Cellular Basis and Ultrastructure of Focal Regions Lacking Endothelial Cell Markers Cancer Res., July 1, 2005; 65(13): 5740 - 5749. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Parsons-Wingerter, I. M. Kasman, S. Norberg, A. Magnussen, S. Zanivan, A. Rissone, P. Baluk, C. J. Favre, U. Jeffry, R. Murray, et al. Uniform Overexpression and Rapid Accessibility of {alpha}5{beta}1 Integrin on Blood Vessels in Tumors Am. J. Pathol., July 1, 2005; 167(1): 193 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Abramowicz Ultrasonographic Contrast Media: Has the Time Come in Obstetrics and Gynecology? J. Ultrasound Med., April 1, 2005; 24(4): 517 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Magnussen, I. M. Kasman, S. Norberg, P. Baluk, R. Murray, and D. M. McDonald Rapid Access of Antibodies to {alpha}5{beta}1 Integrin Overexpressed on the Luminal Surface of Tumor Blood Vessels Cancer Res., April 1, 2005; 65(7): 2712 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ziemer, W. M. F. Lee, S. A. Vinogradov, C. Sehgal, and D. F. Wilson Oxygen distribution in murine tumors: characterization using oxygen-dependent quenching of phosphorescence J Appl Physiol, April 1, 2005; 98(4): 1503 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Yao, M. G. Ozawa, M. Trepel, W. Arap, D. M. McDonald, and R. Pasqualini Targeting Pancreatic Islets with Phage Display Assisted by Laser Pressure Catapult Microdissection Am. J. Pathol., February 1, 2005; 166(2): 625 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, K. Reijnders, S. English, A. T. Yordanov, D. E. Milenic, A. L. Sowers, D. Citrin, M. C. Krishna, T. A. Waldmann, J. B. Mitchell, et al. Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation Clin. Cancer Res., November 15, 2004; 10(22): 7712 - 7720. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Lee, H.-C. Wu, Y.-L. Tseng, and C.-T. Lin A Novel Peptide Specifically Binding to Nasopharyngeal Carcinoma For Targeted Drug Delivery Cancer Res., November 1, 2004; 64(21): 8002 - 8008. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, S. Tong, M. W. Dewhirst, and F. Yuan Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome Mol. Cancer Ther., October 1, 2004; 3(10): 1311 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inai, M. Mancuso, H. Hashizume, F. Baffert, A. Haskell, P. Baluk, D. D. Hu-Lowe, D. R. Shalinsky, G. Thurston, G. D. Yancopoulos, et al. Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts Am. J. Pathol., July 1, 2004; 165(1): 35 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Swenson, F. Costa, R. Minea, R. P. Sherwin, W. Ernst, G. Fujii, D. Yang, and F. S. Markland Jr. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression Mol. Cancer Ther., April 1, 2004; 3(4): 499 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Davie, J. T. Crossno Jr., M. G. Frid, S. E. Hofmeister, J. T. Reeves, D. M. Hyde, T. C. Carpenter, J. A. Brunetti, I. K. McNiece, and K. R. Stenmark Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L668 - L678. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen and P. R. Cullis Drug Delivery Systems: Entering the Mainstream Science, March 19, 2004; 303(5665): 1818 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, M. Li, J. J. Rinehart, and R. Zhang Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts: In Vivo Activity, Pharmacokinetics, and Clinical Implications for Cancer Chemotherapy Clin. Cancer Res., March 1, 2004; 10(5): 1633 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ruddell, P. Mezquita, K. A. Brandvold, A. Farr, and B. M. Iritani B Lymphocyte-Specific c-Myc Expression Stimulates Early and Functional Expansion of the Vasculature and Lymphatics during Lymphomagenesis Am. J. Pathol., December 1, 2003; 163(6): 2233 - 2245. [Abstract] [Full Text] |
||||
![]() |
S A Hoption Cann, J P van Netten, and C van Netten Dr William Coley and tumour regression: a place in history or in the future Postgrad. Med. J., December 1, 2003; 79(938): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Baluk, S. Morikawa, A. Haskell, M. Mancuso, and D. M. McDonald Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., November 1, 2003; 163(5): 1801 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vacca, R. Ria, F. Semeraro, F. Merchionne, M. Coluccia, A. Boccarelli, C. Scavelli, B. Nico, A. Gernone, F. Battelli, et al. Endothelial cells in the bone marrow of patients with multiple myeloma Blood, November 1, 2003; 102(9): 3340 - 3348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rybak, E. Sanovich, M. G. Hollingshead, S. D. Borgel, D. L. Newton, G. Melillo, D. Kong, G. Kaur, and E. A. Sausville "Vasocrine" Formation of Tumor Cell-lined Vascular Spaces: Implications for Rational Design of Antiangiogenic Therapies Cancer Res., June 1, 2003; 63(11): 2812 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Giavazzi, B. Sennino, D. Coltrini, A. Garofalo, R. Dossi, R. Ronca, M. P. M. Tosatti, and M. Presta Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis Am. J. Pathol., June 1, 2003; 162(6): 1913 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Izumi, E. di Tomaso, A. Hooper, P. Huang, J. Huber, D. J. Hicklin, D. Fukumura, R. K. Jain, and H. D. Suit Responses to Antiangiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts Cancer Res., February 15, 2003; 63(4): 747 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kubo and K. Alitalo The bloody fate of endothelial stem cells Genes & Dev., February 1, 2003; 17(3): 322 - 329. [Full Text] [PDF] |
||||
![]() |
M. S. Gee, W. N. Procopio, S. Makonnen, M. D. Feldman, N. M. Yeilding, and W. M. F. Lee Tumor Vessel Development and Maturation Impose Limits on the Effectiveness of Anti-Vascular Therapy Am. J. Pathol., January 1, 2003; 162(1): 183 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Lee, N. Nagai, C.-H. Siar, K. Nakano, H. Nagatsuka, H. Tsujigiwa, C.-H. Roan, and M. Gunduz Angioarchitecture of Primary Oral Malignant Melanomas J. Histochem. Cytochem., November 1, 2002; 50(11): 1555 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tuxhorn, S. J. McAlhany, F. Yang, T. D. Dang, and D. R. Rowley Inhibition of Transforming Growth Factor-{beta} Activity Decreases Angiogenesis in a Human Prostate Cancer-reactive Stroma Xenograft Model Cancer Res., November 1, 2002; 62(21): 6021 - 6025. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. McDonald and P. Baluk Significance of Blood Vessel Leakiness in Cancer Cancer Res., September 15, 2002; 62(18): 5381 - 5385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tuxhorn, S. J. McAlhany, T. D. Dang, G. E. Ayala, and D. R. Rowley Stromal Cells Promote Angiogenesis and Growth of Human Prostate Tumors in a Differential Reactive Stroma (DRS) Xenograft Model Cancer Res., June 1, 2002; 62(11): 3298 - 3307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarijs, I. Otte-Holler, D. J. Ruiter, and R. M. W. de Waal Presence of a Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Human Uveal Melanoma Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 912 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Yu, J. W. Rak, G. Klement, and R. S. Kerbel Vascular Endothelial Growth Factor Isoform Expression as a Determinant of Blood Vessel Patterning in Human Melanoma Xenografts Cancer Res., March 1, 2002; 62(6): 1838 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R. K. Jain, and D. M. McDonald Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., March 1, 2002; 160(3): 985 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sood, M. S. Fletcher, and M. J. C. Hendrix The Embryonic-Like Properties of Aggressive Human Tumor Cells Reproductive Sciences, January 1, 2002; 9(1): 2 - 9. [Abstract] [PDF] |
||||
![]() |
M. ANGHELINA, A. SCHMEISSER, P. KRISHNAN, L. MOLDOVAN, R.H. STRASSER, and N.I. MOLDOVAN Migration of Monocytes/Macrophages In Vitro and In Vivo Is Accompanied by MMP12-dependent Tunnel Formation and by Neovascularization Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 209 - 216. [Abstract] [PDF] |
||||
![]() |
R. PASQUALINI and W. ARAP Profiling the Molecular Diversity of Blood Vessels Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 223 - 226. [Abstract] [PDF] |
||||
![]() |
K. Shirakawa, H. Kobayashi, Y. Heike, S. Kawamoto, M. W. Brechbiel, F. Kasumi, T. Iwanaga, F. Konishi, M. Terada, and H. Wakasugi Hemodynamics in Vasculogenic Mimicry and Angiogenesis of Inflammatory Breast Cancer Xenograft Cancer Res., January 1, 2002; 62(2): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abramsson, O. Berlin, H. Papayan, D. Paulin, M. Shani, and C. Betsholtz Analysis of Mural Cell Recruitment to Tumor Vessels Circulation, January 1, 2002; 105(1): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. MCDONALD Angiogenesis and Remodeling of Airway Vasculature in Chronic Inflammation Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Elson, G. Thurston, L. E. Huang, D. G. Ginzinger, D. M. McDonald, R. S. Johnson, and J. M. Arbeit Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1{alpha} Genes & Dev., October 1, 2001; 15(19): 2520 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hu and A. Garen Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer PNAS, September 26, 2001; (2001) 201420298. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karpanen and K. Alitalo Lymphatic Vessels as Targets of Tumor Therapy? J. Exp. Med., September 17, 2001; 194(6): F37 - F42. [Full Text] [PDF] |
||||
![]() |
T. Ezaki, P. Baluk, G. Thurston, A. La Barbara, C. Woo, and D. M. McDonald Time Course of Endothelial Cell Proliferation and Microvascular Remodeling in Chronic Inflammation Am. J. Pathol., June 1, 2001; 158(6): 2043 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sood, E. A. Seftor, M. S. Fletcher, L. M. G. Gardner, P. M. Heidger, R. E. Buller, R. E. B. Seftor, and M. J. C. Hendrix Molecular Determinants of Ovarian Cancer Plasticity Am. J. Pathol., April 1, 2001; 158(4): 1279 - 1288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |